These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 39233313)

  • 1. Optimizing Tomorrow's Drug Development with Project Optimus: Precision Dosing IS Precision Oncology.
    Subbiah V
    Ann Oncol; 2024 Oct; 35(10):836-839. PubMed ID: 39233313
    [No Abstract]   [Full Text] [Related]  

  • 2. Precision medicine for pediatric cancers lags behind that for adult cancers: Citing hurdles in clinical trial recruitment and drug development, researchers are exploring ways to close gaps.
    Printz C
    Cancer; 2020 Jan; 126(2):239-240. PubMed ID: 31917472
    [No Abstract]   [Full Text] [Related]  

  • 3. Embracing Project Optimus: Can we Leverage Evolutionary Theory to Optimize Dosing in Oncology?
    Qi T; Dunlap T; Cao Y
    Pharm Res; 2022 Dec; 39(12):3259-3265. PubMed ID: 36056271
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Reasons to be testing: the dawn of complex molecular profiling in routine oncology practice.
    Beer PA; Cooke SL; Chang DK; Biankin AV
    Ann Oncol; 2019 Nov; 30(11):1691-1694. PubMed ID: 31665210
    [No Abstract]   [Full Text] [Related]  

  • 5. Oncology Therapy Drugs in China, Japan, and the United States: Pharmacokinetic Characteristics, Dose Regimens, and Development Strategies.
    Zhou L; Higashimori M; Shen K; Zhang Z; Sheng J; Xu H; Horiuchi M; Ichikawa K; Al-Huniti N; Zhou D
    Clin Pharmacol Ther; 2019 Jun; 105(6):1303-1320. PubMed ID: 30802932
    [No Abstract]   [Full Text] [Related]  

  • 6. Giving Up on Precision Oncology? Not So Fast!
    Warner JL
    Clin Transl Sci; 2017 May; 10(3):128-129. PubMed ID: 28146309
    [No Abstract]   [Full Text] [Related]  

  • 7. Precision medicine in pediatric oncology.
    Forrest SJ; Geoerger B; Janeway KA
    Curr Opin Pediatr; 2018 Feb; 30(1):17-24. PubMed ID: 29189430
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ushering in the next generation of precision trials for pediatric cancer.
    DuBois SG; Corson LB; Stegmaier K; Janeway KA
    Science; 2019 Mar; 363(6432):1175-1181. PubMed ID: 30872517
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Delivering on the promise of precision cancer medicine.
    Berger MF; Van Allen EM
    Genome Med; 2016 Oct; 8(1):110. PubMed ID: 27782852
    [No Abstract]   [Full Text] [Related]  

  • 10. Precision Oncology Medicine: The Clinical Relevance of Patient-Specific Biomarkers Used to Optimize Cancer Treatment.
    Schmidt KT; Chau CH; Price DK; Figg WD
    J Clin Pharmacol; 2016 Dec; 56(12):1484-1499. PubMed ID: 27197880
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Current issues in dose-finding designs: A response to the US Food and Drug Adminstration's Oncology Center of Excellence Project Optimus.
    Thall PF; Garrett-Mayer E; Wages NA; Halabi S; Cheung YK
    Clin Trials; 2024 Jun; 21(3):267-272. PubMed ID: 38570906
    [TBL] [Abstract][Full Text] [Related]  

  • 12. N-of-1 Trials in Cancer Drug Development.
    Gouda MA; Buschhorn L; Schneeweiss A; Wahida A; Subbiah V
    Cancer Discov; 2023 Jun; 13(6):1301-1309. PubMed ID: 37070849
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The importance of persistence in cancer drug development.
    Mullard A
    Nat Rev Drug Discov; 2021 Dec; 20(12):890-891. PubMed ID: 34764465
    [No Abstract]   [Full Text] [Related]  

  • 14. Toward Project Optimus for Oncology Precision Medicine: Multi-Dimensional Dose Optimization Enabled by Quantitative Clinical Pharmacology.
    Venkatakrishnan K; van der Graaf PH
    Clin Pharmacol Ther; 2022 Nov; 112(5):927-932. PubMed ID: 36264968
    [No Abstract]   [Full Text] [Related]  

  • 15. The Changing Face of Oncology Research, Drug Development, and Clinical Practice: Toward Patient-Focused Precision Therapeutics.
    Venkatakrishnan K; van der Graaf PH; Holstein SA
    Clin Pharmacol Ther; 2020 Sep; 108(3):399-404. PubMed ID: 33439492
    [No Abstract]   [Full Text] [Related]  

  • 16. Precision medicine and oncology: an overview of the opportunities presented by next-generation sequencing and big data and the challenges posed to conventional drug development and regulatory approval pathways.
    Doherty M; Metcalfe T; Guardino E; Peters E; Ramage L
    Ann Oncol; 2016 Aug; 27(8):1644-6. PubMed ID: 27117532
    [No Abstract]   [Full Text] [Related]  

  • 17. Personalized medicine in oncology: next generation.
    Chiang A; Million RP
    Nat Rev Drug Discov; 2011 Dec; 10(12):895-6. PubMed ID: 22129983
    [No Abstract]   [Full Text] [Related]  

  • 18. 'Flat-fixed dosing' of chemotherapy: a concept whose time has come?
    Markman M
    Curr Oncol Rep; 2005 Jan; 7(1):1-2. PubMed ID: 15610676
    [No Abstract]   [Full Text] [Related]  

  • 19. Personalized Medicine: Genomics Trials in Oncology.
    Hayes DF; Schott AF
    Trans Am Clin Climatol Assoc; 2015; 126():133-43. PubMed ID: 26330667
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Molecular Tumor Boards in Clinical Practice.
    Luchini C; Lawlor RT; Milella M; Scarpa A
    Trends Cancer; 2020 Sep; 6(9):738-744. PubMed ID: 32517959
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.